United States
# |
Name |
Gross Profit |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 6.30 B
|
Sept. 30, 2024 | USD 164.41 | -1.15% |
|
United States |
|
2 |
USD 3.35 B
|
Sept. 30, 2024 | USD 34.46 | -1.96% |
|
United States |
|
3 |
USD 590.85 M
|
Sept. 30, 2024 | USD 8.51 | -1.16% |
|
United States |
|
4 |
USD 216.09 M
|
Sept. 30, 2024 | USD 12.48 | NA |
|
United States |
|
5 |
USD 186.78 M
|
Sept. 30, 2024 | USD 16.32 | -1.03% |
|
United States |
|
6 |
USD 152.16 M
|
Sept. 30, 2024 | USD 16.59 | -4.16% |
|
United States |
|
7 |
USD 83.06 M
|
Sept. 30, 2024 | USD 12.31 | -23.96% |
|
United States |
|
8 |
USD 64.40 M
|
Sept. 30, 2024 | USD 10.23 | -2.76% |
|
United States |
|
9 |
USD 47.92 M
|
Sept. 30, 2024 | USD 1.86 | 4.49% |
|
United States |
|
10 |
USD 23.42 M
|
Sept. 30, 2024 | USD 4.69 | -4.29% |
|
United States |
|
11 |
USD 8.94 M
|
Sept. 30, 2024 | USD 9.38 | -6.57% |
|
United States |
|
12 |
USD 5.67 M
|
Sept. 30, 2024 | USD 3.18 | -5.08% |
|
United States |
|
13 |
USD 638.00 K
|
Sept. 30, 2024 | USD 1.97 | -1.50% |
|
United States |
|
14 |
USD 426.00 K
|
Sept. 30, 2024 | USD 78.14 | -3.73% |
|
United States |
|
15 |
USD 203.52 K
|
Sept. 30, 2024 | USD 2.54 | -7.30% |
|
United States |
|
16 |
USD 116.00 K
|
July 31, 2024 | USD 2.13 | -2.74% |
|
United States |
|
17 |
USD 42.00 K
|
Sept. 30, 2024 | USD 5.96 | -8.87% |
|
United States |
|
18 |
USD -1.12 M
|
Sept. 30, 2024 | USD 2.11 | -0.47% |
|
United States |
|
19 |
USD -1.79 M
|
Sept. 30, 2024 | USD 2.32 | -6.45% |
|
United States |
The Vaccines company in United States with the highest Gross Profit is Zoetis Inc. (NYSE: ZTS) at USD 6.30 B.
The Vaccines company in United States with the lowest Gross Profit is ImmunityBio, Inc. (NasdaqGS: IBRX) at USD -1.79 M.
The top 10 Vaccines companies in United States by Gross Profit are Zoetis Inc., Moderna, Inc., Novavax, Inc., Dynavax Technologies Corporation, ADMA Biologics, Inc., Arcturus Therapeutics Holdings Inc., Atara Biotherapeutics, Inc., Vir Biotechnology, Inc., HOOKIPA Pharma Inc. and TriSalus Life Sciences, Inc..
The bottom 10 Vaccines companies in United States by Gross Profit are ImmunityBio, Inc., GeoVax Labs, Inc., INmune Bio, Inc., Anixa Biosciences, Inc., Marker Therapeutics, Inc., Vaxcyte, Inc., HilleVax, Inc., Arbutus Biopharma Corporation, Immunome, Inc. and TriSalus Life Sciences, Inc..